Enrichment of TREM2+ TAMs is associated with poor clinical outcome in patients with HCC [102] and knock-out of TREM2 was found to suppress the growth of HCC in an in vivo murine model [103]. This evidence concerns the gene TREM2 and hepatocellular carcinoma.